Potentin vitroandin vivoactivity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization-Reference-Cited by-同舟云学术

Potentin vitroandin vivoactivity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization

Published:2013-02-06 Issue:1 Volume:161 Page:104-116
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Udi Josefina¹,Schüler Julia,Wider Dagmar¹,Ihorst Gabriele²,Catusse Julie¹,Waldschmidt Johannes¹,Schnerch Dominik¹,Follo Marie³,Wäsch Ralph¹,Engelhardt Monika¹

Affiliation:

1. Department of Haematology and Oncology; Freiburg University Medical Centre; Freiburg; Germany

2. Clinical Trials Unit; Freiburg University Medical Centre; Germany; Freiburg

3. Department of Haematology and Oncology; Freiburg University Medical Centre; Core facility; Freiburg; Germany

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12226/fullpdf

Reference39 articles.

1. Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib;Alexandrescu;Journal of Clinical Oncology,2008

2. Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis;Badr;PLoS ONE,2011

3. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours;Beck;Nature,2011

4. Tumour biology: skin-cancer stem cells outwitted;Benitah;Nature,2011

5. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization;Bossy-Wetzel;EMBO Journal,1998

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysis;Heliyon;2023-07

2. CCL5 mediates breast cancer metastasis and prognosis through CCR5/Treg cells;Frontiers in Oncology;2022-08-10

3. Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma;Journal of Cancer Research and Clinical Oncology;2022-01-24

4. ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology;Journal of Cellular and Molecular Medicine;2021-10-16

5. An Improved Animal Model of Multiple Myeloma Bone Disease;Cancers;2021-08-25